Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

ClinicalTrials.gov ID: NCT02610283

Public ClinicalTrials.gov record NCT02610283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery

Study identification

NCT ID
NCT02610283
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Quark Pharmaceuticals
Industry
Enrollment
341 participants

Conditions and interventions

Interventions

  • QPI-1002 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Jan 31, 2018
Completion
Mar 31, 2018
Last update posted
Jan 9, 2019

2015 – 2018

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
University of Arizona Sarver Heart Center Tucson Arizona 85724
University of Florida Gainesville Florida 32610
Jacksonville Center for Clinical Research Jacksonville Florida 32216
River City Clinical Research Jacksonville Florida 32216
Advocate Christ Medical Center Oak Lawn Illinois 60453
Indiana Ohio Heart Fort Wayne Indiana 46804
St. Vincent Medical Group Indianapolis Indiana 46290
Johns Hopkins University Baltimore Maryland 21287
Suburban Hospital Bethesda Maryland 20814
Mid Michigan Cardiovascular Research Midland Michigan 48670
Cardiac & Vascular Research Center of Northern Michigan Petoskey Michigan 49770
Washington University St Louis Missouri 63110
Bryan Heart Lincoln Nebraska 68506
Columbia University New York New York 10032
Duke University Durham North Carolina 27710
Lindner Research Center, The Christ Hospital Cincinnati Ohio 45219
Cleveland Clinic Foundation Cleveland Ohio 44111
Ohio State University Medical Center Columbus Ohio 43210
Baylor University Dallas Texas 75246
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02610283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 9, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02610283 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →